Jeung, L

A tumefactive demyelinating lesion in a person with MS after five years of fingolimod. [electronic resource] - Multiple sclerosis and related disorders May 2020 - 101978 p. digital

Publication Type: Case Reports; Journal Article

2211-0356

10.1016/j.msard.2020.101978 doi


Adult
Brain--diagnostic imaging
Fingolimod Hydrochloride--adverse effects
Humans
Immunosuppressive Agents--adverse effects
Magnetic Resonance Imaging
Male
Multiple Sclerosis, Relapsing-Remitting--drug therapy